HLB GenexHLB제넥스
187420 · KOSDAQ · ₩187420 · HLB제넥스
₩2,360▲ ₩105 (4.66%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩11B | ₩12B | ₩12B | ₩10B | ₩10B | ₩11B | ₩10B | ₩9.1B |
| Cost of sales | ₩6.7B | ₩6.7B | ₩8.9B | ₩7.1B | ₩5.7B | ₩6.5B | ₩6B | ₩5.9B |
| Gross profit | ₩4.7B | ₩5B | ₩3.6B | ₩3.1B | ₩4.3B | ₩4.2B | ₩4.1B | ₩3.3B |
| Operating income | ₩983M | ₩1B | −₩655M | −₩384M | ₩1.4B | ₩815M | −₩1.5B | −₩50M |
| Net income | ₩9.4B | −₩2.4B | ₩27B | −₩23B | ₩20B | −₩1.2B | −₩17B | −₩896M |
| Net income to shareholders | ₩6.5B | −₩2.5B | ₩9.1B | −₩3.8B | ₩19B | −₩1.3B | −₩17B | −₩643M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩138B | ₩136B | ₩136B | ₩133B | ₩135B | ₩140B | ₩146B | ₩77B |
| Current assets | ₩54B | ₩51B | ₩50B | ₩54B | ₩64B | ₩81B | ₩97B | ₩25B |
| Cash and equivalents | ₩36B | ₩33B | ₩33B | ₩38B | ₩26B | ₩40B | ₩84B | ₩10B |
| Total liabilities | ₩69B | ₩83B | ₩81B | ₩88B | ₩88B | ₩113B | ₩118B | ₩48B |
| Current liabilities | ₩50B | ₩63B | ₩63B | ₩70B | ₩69B | ₩86B | ₩91B | ₩40B |
| Borrowings | ₩41B | ₩6B | ₩4.6B | ₩5.2B | ₩5.9B | ₩6.5B | ₩7.2B | ₩7.8B |
| Total equity | ₩69B | ₩53B | ₩55B | ₩45B | ₩48B | ₩27B | ₩28B | ₩29B |
| Shareholders' equity | ₩54B | ₩39B | ₩41B | ₩37B | ₩41B | ₩22B | ₩24B | ₩25B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩3.8B | −₩822M | ₩288M | ₩1.7B | ₩3.1B | −₩1.5B | ₩414M | ₩759M |
| Capital spending | −₩232M | −₩613M | −₩61M | −₩472M | −₩157M | −₩132M | −₩184M | −₩153M |
| Free cash flow | ₩3.5B | −₩1.4B | ₩227M | ₩1.2B | ₩2.9B | −₩1.7B | ₩230M | ₩606M |
Consolidated where available. Amounts in won.
Also known as: HLB Genex / HLB제넥스 / 187420 / KRX:187420
Source: KRX statistical information